Published in Dev Neurosci on May 08, 2012
Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem (2006) 1.03
Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation. Biochim Biophys Acta (2010) 1.02
Metabolic multianalyte microphysiometry reveals extracellular acidosis is an essential mediator of neuronal preconditioning. ACS Chem Neurosci (2012) 0.91
Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. J Neurosci (2010) 0.91
Redox modification of proteins as essential mediators of CNS autophagy and mitophagy. FEBS Lett (2013) 0.90
Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia. Exp Neurol (2007) 0.89
Electrophilic cyclopentenone isoprostanes in neurodegeneration. J Mol Neurosci (2007) 0.85
Enrichment of elevated plasma F2t-isoprostane levels in individuals with autism who are stratified by presence of gastrointestinal dysfunction. PLoS One (2013) 0.82
New approaches to neuroprotection in infant heart surgery. Pediatr Res (2010) 0.81
Alteration of isocitrate dehydrogenase following acute ischemic injury as a means to improve cellular energetic status in neuroadaptation. CNS Neurol Disord Drug Targets (2013) 0.76
Estimating index of refraction from polarimetric hyperspectral imaging measurements. Opt Express (2016) 0.75